H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Census population 134,023. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Haven clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Haven storefront.
Growth Factor Therapy for Tissue Repair in New Haven, CT for clinics & physicians. Growth factor therapy p… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a Connecticut chart is a denial pattern. You are JK. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Use Connecticut Department of Public Health for community education; use the IFU for the product in the fridge. growth factor therapy is the SKU conversation, not a patient appointment book.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)Three grains, kept separate on purpose. City: Census 134,023 and CDC PLACES crude rates. State: Connecticut Department of Public Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and National Government Services (NGS) LCDs. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a New Haven trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 11.7% of adults — 0.3 points below the U.S. 12% figure. Obesity is 37.9%; arthritis is 20.3%. That is place-level BRFSS modeling, not a clinic census and not a New Haven trial.
No. Organization schema on this site does not publish a fake aggregateRating. Testimonials on marketing pages are not assigned to New Haven as local reviews.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Connecticut.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in New Haven, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Haven is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Haven — 0.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Haven. Useful for joint-program math; still needs a diagnosis and privileging.
No New Haven storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.